Utility of Post-Transplant Anti-HLA Antibody Measurements in Pediatric Cardiac Transplant Recipients

Class II anti-HLA antibodies correlate with worse patient outcomes and rejection episodes after pediatric cardiac transplant. A low sensitivity precludes use as a sole diagnostic tool, but post-transplant PRAs may be an important adjunct in a multi-faceted algorithm to assess immunologic status.